← All stocks

Syndax Pharmaceuticals Inc

SNDX No buying or selling

CIK 0001395937 #2145 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

11 insiders · 0 transactions

15.5×

Michael A. Metzger holds 15.5 times base salary in stock. $11.75M of shares against $754.30K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael A. Metzger last reported holding, valued at $24.24, the price Common Stock was last bought or sold at on the open market here, on 8 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Metzger Michael A

Chief Executive Officer

—

484,843

$11.75M

+195.8%

Podlesak Dennis

Director

—

239,763

$5.81M

+69.1%

Goldan Keith A.

Chief Financial Officer

—

139,252

$3.38M

+164.6%

Katkin Keith

Director

—

124,000

$3.01M

+90.8%

Jarrett Jennifer

Director

—

114,000

$2.76M

+75.4%

Legault Pierre

Director

—

114,000

$2.76M

+75.4%

Huber Martin H. Jr.

Director

—

103,000

$2.50M

+110.2%

Meury William

Director

—

90,000

$2.18M

+38.5%

Gallagher Neil

President, Head of R&D

—

85,095

$2.06M

+78.0%

Botwood Nicholas A.J.

Head of R&D, CMO

—

60,885

$1.48M

+6,780%

Rizo Aleksandra

Director

—

49,000

$1.19M

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 2 Nov 2016